- 1 Green cell = fully reported. Yellow cell = partially reported. Red cell = not reported
- 2 Explanation of the mERA items (see [18] for full descriptions): 1: Clearly presents the availability of infrastructure to support technology operations in the study location. 2: Describes and provides justification for the technology architecture. 3: Describes how mHealth intervention can integrate into existing health information systems. 4: The delivery of the mHealth intervention is clearly described. 5: Details of the content of the intervention are described. Source and any modifications of the intervention content is described. 6: Describes formative research and/or content and/or usability testing with target group(s) clearly identified, as appropriate. 7: Describes user feedback about the intervention or user satisfaction with the intervention. 8: Mentions barriers or facilitators to the adoption of the intervention among study participants. 9: Presents basic costs assessment of the mHealth intervention from varying perspectives. 10: Describes how people are informed about the programme including training, if relevant. 11: Clearly presents mHealth solution limitations for delivery at scale. 12: Describes the adaptation, or not, of the solution to a different language, different population or context. 13: Detailed intervention to support replicability. 14: Describes the data security procedures/ confidentiality protocols. 15: Mechanism used to assure that content or other guidance/information provided by the intervention is in alignment with existing national/regulatory guidelines and is described. 16: Was the intervention delivered as planned?
